Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1591547968;47969;47970 chr2:178617342;178617341;178617340chr2:179482069;179482068;179482067
N2AB1427443045;43046;43047 chr2:178617342;178617341;178617340chr2:179482069;179482068;179482067
N2A1334740264;40265;40266 chr2:178617342;178617341;178617340chr2:179482069;179482068;179482067
N2B685020773;20774;20775 chr2:178617342;178617341;178617340chr2:179482069;179482068;179482067
Novex-1697521148;21149;21150 chr2:178617342;178617341;178617340chr2:179482069;179482068;179482067
Novex-2704221349;21350;21351 chr2:178617342;178617341;178617340chr2:179482069;179482068;179482067
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: P
  • RefSeq wild type transcript codon: CCT
  • RefSeq wild type template codon: GGA
  • Domain: Fn3-3
  • Domain position: 57
  • Structural Position: 83
  • Q(SASA): 0.1205
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
P/L None None 1.0 N 0.693 0.434 0.61503831477 gnomAD-4.0.0 6.99811E-07 None None None None I None 0 0 None 0 0 None 0 0 9.10016E-07 0 0
P/T None None 1.0 N 0.727 0.366 0.353974658523 gnomAD-4.0.0 1.67857E-06 None None None None I None 0 0 None 0 0 None 0 0 2.96725E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
P/A 0.1226 likely_benign 0.1299 benign -0.867 Destabilizing 1.0 D 0.685 prob.neutral N 0.473499592 None None I
P/C 0.6761 likely_pathogenic 0.6872 pathogenic -0.797 Destabilizing 1.0 D 0.689 prob.neutral None None None None I
P/D 0.3575 ambiguous 0.3542 ambiguous -0.53 Destabilizing 1.0 D 0.717 prob.delet. None None None None I
P/E 0.257 likely_benign 0.2583 benign -0.58 Destabilizing 1.0 D 0.725 prob.delet. None None None None I
P/F 0.7545 likely_pathogenic 0.7842 pathogenic -0.741 Destabilizing 1.0 D 0.659 neutral None None None None I
P/G 0.259 likely_benign 0.2822 benign -1.086 Destabilizing 1.0 D 0.713 prob.delet. None None None None I
P/H 0.2422 likely_benign 0.2458 benign -0.467 Destabilizing 1.0 D 0.645 neutral N 0.509757789 None None I
P/I 0.6327 likely_pathogenic 0.675 pathogenic -0.406 Destabilizing 1.0 D 0.695 prob.neutral None None None None I
P/K 0.2479 likely_benign 0.2536 benign -0.781 Destabilizing 1.0 D 0.719 prob.delet. None None None None I
P/L 0.2508 likely_benign 0.2751 benign -0.406 Destabilizing 1.0 D 0.693 prob.neutral N 0.470132343 None None I
P/M 0.5204 ambiguous 0.561 ambiguous -0.497 Destabilizing 1.0 D 0.647 neutral None None None None I
P/N 0.2892 likely_benign 0.3131 benign -0.637 Destabilizing 1.0 D 0.701 prob.neutral None None None None I
P/Q 0.1635 likely_benign 0.1717 benign -0.812 Destabilizing 1.0 D 0.726 prob.delet. None None None None I
P/R 0.196 likely_benign 0.1905 benign -0.239 Destabilizing 1.0 D 0.695 prob.neutral N 0.47766196 None None I
P/S 0.1204 likely_benign 0.1271 benign -1.073 Destabilizing 1.0 D 0.735 prob.delet. N 0.471907809 None None I
P/T 0.1431 likely_benign 0.1569 benign -1.013 Destabilizing 1.0 D 0.727 prob.delet. N 0.463565228 None None I
P/V 0.4197 ambiguous 0.455 ambiguous -0.524 Destabilizing 1.0 D 0.693 prob.neutral None None None None I
P/W 0.7601 likely_pathogenic 0.7658 pathogenic -0.856 Destabilizing 1.0 D 0.684 prob.neutral None None None None I
P/Y 0.6129 likely_pathogenic 0.6437 pathogenic -0.57 Destabilizing 1.0 D 0.673 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.